does semaglutide help pcos Common Side Effects of Weight Loss Drugs in - Oana Ozempic (Semaglutide) for PMOS/PCOS: Pelvic

Endocr Pract

Key Market Highlights The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 The market is expected to reach US$ 211.8 Billion by 2035 The industry is forecast to expand at a CAGR of 13.7% during 2025-2035 North America accounted for the largest market share of 68.4% in 2024 The Subcutaneous route of administration segment held 78.2% market share in 2024 Major industry participants include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and AstraZeneca Rising Type 2 Diabetes Cases Accelerating Market Growth The growing prevalence of type 2 diabetes remains one of the most significant growth drivers for the GLP-1 analogues market

Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials[J]

Improves blood flow to the scalp and reduces inflammation

Key Takeaway Individuals using GLP-1 medications may experience sulfur burps due to the combination of dietary choices and the medications effects on their digestive processes